ClinicalTrials.gg
RecruitingNCT07717463Updated Jul 31, 2026

Pericapsular Nerve Group Block Versus Femoral Nerve Block Study

An interventional study of Ultrasound-Guided Pericapsular Nerve Group (PENG) Block and Ultrasound-Guided Femoral Nerve Block in Hip Fractures, sponsored by Taksim Egitim ve Arastirma Hastanesi. Recruiting at 2 sites in Turkey (Türkiye). Open to participants aged 50 Years and older. Per ClinicalTrials.gov, last updated 2026-07-31.

Sponsored by Taksim Egitim ve Arastirma Hastanesi · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Jul 2026; still recruiting 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
110
Allocation
Randomized
Ages
50 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 78 studies in Hip Fractures with a site in Turkey — 14 open to participants now, 18 under way, none of them phase 3. Hip Fractures · Turkey.

Planned enrollment
6th of 38
110 · median 67
Started
2026
with 10 others
No phase
32 of 78
5 open now
Primary completion
2026-12
later than 11 of 17 live
Registered
75th of 78
by date

Among the 78 studies in Hip Fractures with a site in Turkey, this one is the 6th largest by planned enrollment of the 38 interventional ones that give a count, is one of 11 that started in 2026, is one of 32 with no phase, reaches primary completion later than 11 of the 17 other live ones, and was the 75th registered.

Hip Fractures

843 studies on the registry are indexed under Hip Fractures; 166 are open to participants now.

Browse Hip Fractures studies →

Open to participants now

14 of the 78 studies in Hip Fractures with a site in Turkey are open now. Recruiting first, the newest first:

8 more — sign in →

All 14 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 104 Hip Fractures studies recruiting now, 82 (79%) set no upper age limit and 6 (6%) stop at 75 or younger; 12 take children under 18; 9 take healthy volunteers.

This study: 50 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 78 studies in Hip Fractures with a site in Turkey, or all of them as a file.
02

Study summary

Hip fractures are common in older adults and are often associated with severe pain, making it difficult for patients to sit for spinal anesthesia before surgery. Peripheral nerve blocks may improve pain control and facilitate patient positioning, but it remains uncertain whether the Pericapsular Nerve Group (PENG) block provides advantages over the traditional femoral nerve block during the spinal anesthesia procedure.

Read the detailed description

Hip fractures are among the most common injuries in older adults and are associated with substantial morbidity, mortality, and healthcare utilization. Spinal anesthesia is frequently used for surgical repair of proximal femur fractures because of its favorable safety profile in elderly patients. However, severe pain caused by the fracture often makes positioning for spinal anesthesia difficult, resulting in patient discomfort, prolonged procedure time, multiple needle insertion attempts, and increased procedural complexity.

Peripheral nerve blocks are increasingly used before spinal anesthesia to improve analgesia and facilitate patient positioning. The femoral nerve block (FNB) has long been established as an effective regional anesthesia technique for patients with hip fractures. More recently, the ultrasound-guided Pericapsular Nerve Group (PENG) block has been introduced as a motor-sparing technique targeting the articular branches of the femoral, obturator, and accessory obturator nerves that innervate the anterior hip capsule. Previous studies have demonstrated that the PENG block provides effective analgesia during positioning for spinal anesthesia and may offer superior pain relief compared with conventional techniques. However, evidence comparing the effects of PENG block and femoral nerve block on the technical performance of spinal anesthesia and perioperative hemodynamic stability remains limited.

This prospective, randomized controlled trial is designed to compare ultrasound-guided PENG block with ultrasound-guided femoral nerve block in patients undergoing surgery for proximal femur fracture under spinal anesthesia. The study will evaluate whether PENG block improves procedural conditions for spinal anesthesia compared with femoral nerve block while also assessing perioperative analgesia and hemodynamic responses.

The study hypothesis is that preoperative PENG block will provide better procedural conditions for spinal anesthesia than femoral nerve block by improving patient positioning, reducing pain during positioning, facilitating spinal needle placement, decreasing the need for supplemental analgesic or sedative medication, and contributing to greater perioperative hemodynamic stability.

03

Conditions studied

  • Hip Fractures

Browse trials for

Keywords

  • Hip Fracture
  • Pericapsular Nerve Group Block
  • Femoral Nerve Block
  • Regional Anesthesia
  • Spinal Anesthesia
  • Hemodynamic Stability
04

Who can participate

Ages eligible
50 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 50 years or older.
  • Diagnosis of proximal femoral fracture.
  • Scheduled to undergo surgical repair under spinal anesthesia.
  • (ASA) physical status I-III.
  • Able to provide written .

Exclusion criteria

Exclusion Criteria:

  • Refusal to participate or inability to provide .
  • Coagulopathy or to spinal anesthesia or peripheral nerve block.
  • Local infection at the planned injection site.
  • Known allergy or to local anesthetics.
  • Pre-existing neurological disease affecting lower extremity function or sensory assessment.
  • Cognitive impairment preventing reliable study participation or outcome assessment.
  • Previous lumbar spine surgery.
  • Polytrauma.
  • (BMI) \<18 kg/m² or >40 kg/m².
  • Current anticoagulant therapy that precludes neuraxial anesthesia or peripheral nerve block according to institutional practice.
Terms in these criteria, in plain language(5)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
110 participants (estimated)

Study arms

  • Active comparator
    PENG Block

    Participants will receive a preoperative ultrasound-guided Pericapsular Nerve Group (PENG) block with 20 mL of 0.25% bupivacaine before spinal anesthesia for proximal femur fracture surgery. Spinal anesthesia will subsequently be performed according to the standardized study protocol.

    Procedure: Ultrasound-Guided Pericapsular Nerve Group (PENG) Block · Procedure: Spinal Anesthesia (bupivacaine)

  • Active comparator
    Femoral Nerve Block

    Participants will receive a preoperative ultrasound-guided femoral nerve block with 20 mL of 0.25% bupivacaine before spinal anesthesia for proximal femur fracture surgery. Spinal anesthesia will subsequently be performed according to the standardized study protocol.

    Procedure: Ultrasound-Guided Femoral Nerve Block · Procedure: Spinal Anesthesia (bupivacaine)

Interventions

  • ProcedureUltrasound-Guided Pericapsular Nerve Group (PENG) Block

    Ultrasound-guided PENG block performed before spinal anesthesia using 20 mL of 0.25% bupivacaine to provide analgesia for patients undergoing surgery for proximal femur fracture.

  • ProcedureUltrasound-Guided Femoral Nerve Block

    Ultrasound-guided femoral nerve block performed before spinal anesthesia using 20 mL of 0.25% bupivacaine to provide analgesia for patients undergoing surgery for proximal femur fracture.

  • ProcedureSpinal Anesthesia (bupivacaine)

    Standard spinal anesthesia performed after the assigned peripheral nerve block using intrathecal hyperbaric bupivacaine according to the study protocol.

06

What researchers measure

Primary outcomes

  1. Spinal Anesthesia Convenience Score (SACS)

    Spinal anesthesia convenience will be assessed using the Spinal Anesthesia Convenience Score (SACS), a composite clinical score evaluating the ease of spinal anesthesia based on anatomical landmark palpation, patient cooperation, sitting position quality, pain during passive hip flexion, and pain while maintaining the sitting position. Total scores range from 0 to 11, with higher scores indicating easier spinal anesthesia conditions.

    Time frame: During spinal anesthesia procedure (immediately after patient positioning and before initiation of surgery)

Secondary outcomes

  1. First-Attempt Success of Spinal Anesthesia

    The proportion of participants in whom successful intrathecal access is achieved on the first needle insertion attempt.

    Time frame: During the spinal anesthesia procedure.

  2. Number of Spinal Needle Insertion Attempts

    The total number of spinal needle insertion attempts required to achieve successful spinal anesthesia.

    Time frame: During the spinal anesthesia procedure.

  3. Duration of Spinal Anesthesia Procedure

    Time from the beginning of patient positioning until completion of spinal anesthesia and return to the supine position, measured in minutes.

    Time frame: During the spinal anesthesia procedure.

  4. Anxiety Score

    Patient anxiety will be assessed using an 11-point Numeric Rating Scale (NRS) ranging from 0 (no anxiety) to 10 (maximum anxiety). Lower scores indicate less anxiety.

    Time frame: Before peripheral nerve block, 30 minutes after block placement, and immediately before surgical incision (after spinal anesthesia).

  5. Patient Satisfaction

    Patient satisfaction with the anesthesia process will be assessed using a Numeric Rating Scale ranging from 0 (not satisfied at all) to 10 (completely satisfied). Higher scores indicate greater satisfaction.

    Time frame: Postoperative Day 0 (before discharge from the post-anesthesia care unit [PACU])

  6. Anesthesiologist Satisfaction

    The anesthesiologist's satisfaction with procedural conditions will be assessed using a Numeric Rating Scale ranging from 0 (not satisfied at all) to 10 (completely satisfied). Higher scores indicate greater satisfaction.

    Time frame: Immediately after completion of spinal anesthesia.

  7. Perioperative Hemodynamic Parameters

    Mean arterial blood pressure will be recorded throughout the perioperative period.

    Time frame: Before peripheral nerve block; 1, 5, 10, 15, and 30 minutes after block placement; and 1, 5, 10, 15, and 30 minutes after spinal anesthesia.

  8. Incidence of Hypotension

    Hypotension is defined as a mean arterial pressure below 65 mmHg. The proportion of participants experiencing hypotension will be recorded.

    Time frame: From spinal anesthesia until 30 minutes after surgery completed.

  9. Vasopressor Requirement

    Total intravenous ephedrine dose administered for the treatment of hypotension, measured in milligrams.

    Time frame: From spinal anesthesia until 30 minutes after surgery completed.

  10. Additional Analgesic Medication Requirement

    Total doses of intravenous fentanyl (micrograms) administered during positioning for spinal anesthesia.

    Time frame: During the spinal anesthesia procedure.

  11. Additional Sedative Medication Requirement

    Total doses of intravenous midazolam (milligrams) administered during positioning for spinal anesthesia.

    Time frame: During the spinal anesthesia procedure.

07

Study locations

1 of 2 sites recruiting
08

References and documents

Publications

  • Messina A, La Via L, Milani A, Savi M, Calabro L, Sanfilippo F, Negri K, Castellani G, Cammarota G, Robba C, Morenghi E, Astuto M, Cecconi M. Spinal anesthesia and hypotensive events in hip fracture surgical repair in elderly patients: a meta-analysis. J Anesth Analg Crit Care. 2022 May 8;2(1):19. doi: 10.1186/s44158-022-00047-6. PubMed 37386657 ↗
  • Giron-Arango L, Peng PWH, Chin KJ, Brull R, Perlas A. Pericapsular Nerve Group (PENG) Block for Hip Fracture. Reg Anesth Pain Med. 2018 Nov;43(8):859-863. doi: 10.1097/AAP.0000000000000847. PubMed 30063657 ↗
  • Beaudoin FL, Nagdev A, Merchant RC, Becker BM. Ultrasound-guided femoral nerve blocks in elderly patients with hip fractures. Am J Emerg Med. 2010 Jan;28(1):76-81. doi: 10.1016/j.ajem.2008.09.015. PubMed 20006206 ↗
  • Erten E, Kara U, Simsek F, Eskin MB, Bilekli AB, Ocal N, Senkal S, Ozdemirkan I. Comparison of pericapsular nerve group block and femoral nerve block in spinal anesthesia position analgesia for proximal femoral fractures in geriatric patients: a randomized clinical trial. Ulus Travma Acil Cerrahi Derg. 2023 Dec;29(12):1368-1375. doi: 10.14744/tjtes.2023.33389. PubMed 38073453 ↗
  • Lin DY, Brown B, Morrison C, Kroon HM, Jaarsma RL. Pericapsular nerve group block results in a longer analgesic effect and shorter time to discharge than femoral nerve block in patients after hip fracture surgery: a single-center double-blinded randomized trial. J Int Med Res. 2022 Mar;50(3):3000605221085073. doi: 10.1177/03000605221085073. PubMed 35291842 ↗
  • Aygun H, Tulgar S, Yigit Y, Tasdemir A, Kurt C, Genc C, Bilgin S, Senoglu N, Koksal E. Effect of ultrasound-guided pericapsular nerve group (PENG) block on pain during patient positioning for central nervous blockade in hip surgery: a randomized controlled trial. BMC Anesthesiol. 2023 Sep 15;23(1):316. doi: 10.1186/s12871-023-02245-3. PubMed 37715173 ↗

Individual participant data

Plan to share: No — There is no current plan to share individual participant data (IPD). Future data sharing may be considered upon reasonable request and subject to approval by the sponsor, institutional policies, and applicable ethical and legal requirements.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2026 (actual). Primary completion is estimated for Dec 2026, 4 months after the start.

Of 221 non-industry interventional studies with no phase under Hip Fractures, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 55. This study's planned 4 months is below that.

Counting every sponsor, half of 237 studies reached it within 29 months; a quarter within 10 and three quarters within 57.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 6, 2026
First posted
Jul 21, 2026
StartActual
Jul 22, 2026
Primary completionEst.
Dec 14, 2026
CompletionEst.
Dec 22, 2026
Last update
Jul 31, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 31, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07717463
Lead sponsor
Taksim Egitim ve Arastirma Hastanesi
Responsible party
Sponsor
First posted
Jul 21, 2026
Start date
Jul 22, 2026
Primary completion
Dec 14, 2026 (estimated)
Completion
Dec 22, 2026 (estimated)
Last update
Jul 31, 2026

Study contacts

Celal Kaya, MD
Contact
c.kaya47@hotmail.com
90 5435176760
Celal Kaya
principal investigator · Taksim Training and Research Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion